Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Aurobindo Pharma Annual Report

Aurobindo Pharma Limited has submitted its Integrated Annual Report for FY 2025-26, alongside the notice for its 39th Annual General Meeting.

Source

BSE filing, NSE: AUROPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Aurobindo Pharma Ltd: key numbers

Share price
₹1,694.50
Market cap
₹98,417 Cr
Revenue (annual)
₹33,653 Cr
Net profit (annual)
₹3,505 Cr
P/E (TTM)
25.0×Sector 41.3×
Promoter holding
51.88%+0.00% QoQ
FII holding
17.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aurobindo Pharma Ltd

All →

Other annual report announcements

All →